Pathological complete response after monotherapy with immune checkpoint inhibitors for bifocal colon cancer in a patient with lynch syndrome and situs inversus totalis: a case report

Jun Feng, Wenbo Niu, Juan Zhang, Yuanyi Ding, Zheng Li, Jianfeng Zhang, Baokun Li, Chenhui Li, Fangfang Wang, Guiying Wang, Bin YuFrontiers in Immunology 2025 · DOI

Abstract

The anatomical variations associated with SIT increase the complexity of surgical procedures. Advanced imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are essential for assessing fine anatomical details and facilitating surgery. ICIs are an effective treatment option for Lynch syndrome-associated CRC, as demonstrated in this case. Future studies should investigate the optimal timing of immunotherapy, combination treatment strategies, and methods to mitigate immune-related toxicities. Such research will help develop comprehensive and personalized treatment plans for Lynch syndrome-associated CRC.

Introduction

This case report documents a rare clinical intersection involving hereditary genetics and congenital anatomical variation: a patient with Lynch syndrome and situs inversus totalis (SIT) who achieved a pathological complete response (pCR) to immunotherapy for bifocal colon cancer. While the treatment proved exceptionally effective, it triggered a life-threatening intestinal perforation due to rapid tumor regression. This highlights both the transformative power and the procedural risks associated with immune checkpoint inhibitors (ICIs) in specific patient populations.

Case Presentation and Imaging

A 48-year-old male presented with abdominal symptoms and was diagnosed with bifocal adenocarcinoma. Diagnostic workup included contrast-enhanced CT and electronic colonoscopy. Genetic profiling confirmed Lynch syndrome with a microsatellite instability-high (MSI-H) status, making the patient an ideal candidate for immunotherapy.

CT imaging demonstrating situs inversus totalis (A) and the subsequent intestinal perforation (B-D).

The patient's condition was further complicated by situs inversus totalis, a rare condition where major visceral organs are mirrored. As seen in the coronal CT scan (A), the transposed anatomy necessitates a complete reversal of standard surgical approaches. During treatment with sintilimab (an anti-PD-1 antibody at 200 mg every three weeks), the patient experienced a sudden gastrointestinal perforation after seven cycles, visualized in the axial views (B-D).

Methods and Treatment Strategy

The clinical management involved a multidisciplinary approach:

  • Immunotherapy: Monotherapy with sintilimab was initiated based on the MSI-H status.
  • Emergency Surgery: Following the perforation, an emergency exploratory laparotomy was required. The SIT necessitated that the lead surgeon stand on the patient’s right side—the opposite of standard protocol—to manage the transposed ascending and descending colons.
  • Follow-up Surgery: Years later, the patient underwent a laparoscopic colostomy reversal and proximal colectomy.
  • Pathological Assessment: Resected tissue was evaluated using the Tumor Regression Grade (TRG) system.

Key Results and Insights

Pathological Complete Response (pCR)

The most significant outcome was the achievement of a pCR. The final pathological examination of the resected colon revealed a TRG of 0, indicating no residual cancer cells remained, only scarred tissue. As of June 2024, over three years post-diagnosis, the patient remains cancer-free with no recurrence or metastasis. Biomarkers, including CEA, normalized and remained stable throughout the follow-up period.

The Double-Edged Sword of Efficacy

The rapid regression of the tumor, while a sign of treatment success, led directly to the intestinal perforation. In MSI-H patients, the intestinal wall may lose structural integrity before it can heal during aggressive ICI-induced shrinkage. This suggests that clinicians must remain vigilant for "perforation due to regression," which can mimic disease progression but requires vastly different management.

Discussion and Limitations

SIT presents unique challenges for surgical ergonomics, requiring careful preoperative planning and advanced imaging to navigate the mirrored anatomy. Furthermore, this case reinforces that ICI monotherapy can be sufficient for pCR in Lynch syndrome-associated CRC, potentially sparing patients the toxicities of traditional chemotherapy.

However, as a single case report ($N=1$), these results cannot be generalized. The optimal timing for surgery following immunotherapy remains unclear; operating too early may miss a pCR, while waiting too long increases the risk of perforation or immune-related adverse events.

Conclusion

This case underscores the necessity of personalized treatment plans for Lynch syndrome-associated CRC, especially when complicated by anatomical variations like SIT. Future research should focus on standardized protocols for SIT surgeries and strategies to mitigate the risk of perforation during rapid tumor regression under immunotherapy.

Summary updated

Abstract

The anatomical variations associated with SIT increase the complexity of surgical procedures. Advanced imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are essential for assessing fine anatomical details and facilitating surgery. ICIs are an effective treatment option for Lynch syndrome-associated CRC, as demonstrated in this case. Future studies should investigate the optimal timing of immunotherapy, combination treatment strategies, and methods to mitigate immune-related toxicities. Such research will help develop comprehensive and personalized treatment plans for Lynch syndrome-associated CRC.
BibTeX
@inproceedings{feng2025pathological,
  author = {Jun Feng and Wenbo Niu and Juan Zhang and Yuanyi Ding and Zheng Li and Jianfeng Zhang and Baokun Li and Chenhui Li and Fangfang Wang and Guiying Wang and Bin Yu},
  title = {{Pathological complete response after monotherapy with immune checkpoint inhibitors for bifocal colon cancer in a patient with lynch syndrome and situs inversus totalis: a case report}},
  booktitle = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1571607},
}
Figure